Delhi Man Takes HIV Prevention Drugs on AI Advice, Lands in ICU

Published On 2026-01-31 12:34 GMT | Update On 2026-01-31 12:34 GMT

hiv

New Delhi: A Delhi-based man is reportedly in a critical condition after consuming HIV preventive medication based on guidance received from an artificial intelligence (AI) platform, renewing concerns over self-medication and the growing reliance on digital tools for medical advice.

As per available information, the individual allegedly began taking HIV post-exposure prophylaxis (PEP) drugs without consulting a qualified healthcare professional. Shortly after initiating the medication, he developed serious health complications and had to be admitted to a hospital, where doctors described his condition as critical. The adverse reaction is suspected to be linked to the unsupervised use of the drugs.

Medical professionals have reiterated that HIV preventive medicines are prescription-only drugs and should be taken strictly under medical supervision. These medicines are recommended only after proper medical evaluation, and inappropriate or unnecessary intake can result in severe side effects, including potentially life-threatening drug reactions.

Also Read: Siddha student found dead under mysterious circumstances in Tamil Nadu

The incident has highlighted the risks associated with relying on AI-based platforms for health-related decisions. Experts have cautioned that while such tools may provide general information, they cannot evaluate an individual’s medical history, current health status, or suitability for specific medications, making them unsafe substitutes for professional medical advice.

According to a report by The Times of India, doctors and public health experts have urged people to avoid self-medication and to consult registered medical practitioners before starting any treatment, especially for serious conditions such as HIV prevention. They also stressed the need for greater public awareness about the limitations of AI-generated health advice.

Also Read: Three Family Members Test HIV-Positive, Chaibasa Sadar Hospital under scrutiny

Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Parthika Patel

Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Delhi Man Takes HIV Prevention Drugs on AI Advice, Lands in ICU

Similar News

AI Reshapes Drug Development Workflows, But Breakthrough Molecules Still Elusive

USFDA, EMA Issue First Joint Guidelines on Safe Use of AI in Drug Development

Eli Lilly, Nimbus Tie Up in USD 1.35 Billion AI-Driven Pact to Develop Oral Obesity Drugs

Shukra Pharma Signs MoU With US Firm for AI Surgical Robotics in India